Pirfenidone in patients with progressive fibrotic interstitial lung ...

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, ...

Pirfenidone in patients with progressive fibrotic interstitial ... - PubMed

Background: Pirfenidone has been shown to slow disease progression in patients with idiopathic pulmonary fibrosis (IPF). However, there are few ...

Pirfenidone in Progressive Pulmonary Fibrosis - ATS Journals

Conclusions: Pirfenidone use in patients with PPF is associated with a statistically significant decrease in disease progression and with ...

Pirfenidone in patients with progressive fibrotic interstitial lung ...

We aimed to assess the efficacy and safety of pirfenidone in patients with four non-IPF progressive fibrotic ILDs.

Pirfenidone in patients with progressive fibrotic interstitial lung ...

Pirfenidone has been shown to slow disease progression in patients with idiopathic pulmonary fibrosis (IPF). However, there are few treatment ...

Pirfenidone in patients with unclassifiable progressive fibrosing ...

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.

Use of pirfenidone in fibrotic interstitial lung diseases and beyond

Pirfenidone has been utilized in IPF treatment for more than one decade. However, guidelines for progressive pulmonary fibrosis (PPF) treatment ...

Pirfenidone in Progressive Pulmonary Fibrosis: A Systematic ...

... pulmonary fibrosis; antifibrotic ... Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis.

Pirfenidone in patients with rapidly progressive interstitial lung ...

Pirfenidone, a new oral antifibrotic agent, has been approved for the treatment of idiopathic pulmonary fibrosis (IPF). Randomized controlled ...

Safety, tolerability, and efficacy of pirfenidone in patients with ...

Pirfenidone has been approved for the treatment of idiopathic pulmonary fibrosis, which prompted to explore its use beyond lung fibrosis. Show abstract.

Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung ...

placebo in patients with progressive fibrosing uILD over 24 weeks (hereafter referred to as the pirfenidone in uILD study; NCT03099187) (9). In ...

Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases ...

Pirfenidone and nintedanib are antifibrotic medications approved for idiopathic pulmonary fibrosis treatment by regulatory agencies and available for ...

Pirfenidone in patients with unclassifiable progressive fibrosing ...

Introduction Despite extensive multidisciplinary team (MDT) assessment, some patients have interstitial lung disease (ILD) that is ...

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary ...

In two of three phase 3 trials, pirfenidone, an oral antifibrotic therapy, reduced disease progression, as measured by the decline in forced ...

Exploring efficacy and safety of oral Pirfenidone for progressive, non ...

Pirfenidone is currently approved in the EU for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) and offers a ...

Pirfenidone safety and adverse event management in idiopathic ...

Pirfenidone is one of two approved therapies for the treatment of idiopathic pulmonary fibrosis (IPF). Randomised controlled clinical trials and subsequent ...

Pirfenidone in Unclassifiable Interstitial Lung Disease - SpringerLink

This was a multicenter, international, double-blind, randomized, placebo-controlled phase II trial of patients with progressive fibrosing uILD ( ...

Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond

Pirfenidone (PFD) slows the progression of idiopathic pulmonary fibrosis (IPF) by inhibiting the exaggerated fibrotic response and possibly through additional ...

Pirfenidone in patients with progressive fibrotic interstitial lung ...

Request PDF | Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis ...

Utilizing Pirfenidone in ILD Treatment Strategy

If you look at the totality of the data for pirfenidone for the approval of IPF [idiopathic pulmonary fibrosis], it's very similar if not ...